GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
12:05:08 18/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,877.40 INR | +6.46% |
|
+10.63% | +16.32% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 488B 5.1B 4.4B 4.14B 3.77B 7.08B 7.19B 48.59B 19.04B 244B 19.14B 18.72B 814B | P/E 2027 * |
42.1x | P/E 2028 * | 36.6x |
|---|---|---|---|---|---|
| Enterprise Value | 488B 5.1B 4.4B 4.14B 3.77B 7.08B 7.19B 48.59B 19.04B 244B 19.14B 18.72B 814B | EV / Sales 2027 * |
11.5x | EV / Sales 2028 * | 10.4x |
| Free-Float |
-
| Yield 2027 * |
1.02% | Yield 2028 * | 1.02% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +6.46% | ||
| 1 week | +10.63% | ||
| Current month | +8.36% | ||
| 1 month | +17.22% | ||
| 3 months | +17.98% | ||
| 6 months | +10.52% | ||
| Current year | +16.32% |
| 1 week | 2,579.5 |  | 2,919 |
| 1 month | 2,445.4 | | 2,919 |
| Current year | 2,088.1 | | 2,919 |
| 1 year | 2,088.1 | | 2,919 |
| 3 years | 1,385.05 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 30/11/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 31/03/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 07/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 31/03/2019 |
| Director/Board Member | 59 | 17/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 15/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.46% | +10.63% | - | - | 4.78B | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,055B | |
| +3.33% | +4.35% | +53.82% | +57.17% | 632B | |
| +3.43% | +3.53% | +25.34% | +72.45% | 442B | |
| +1.35% | -3.27% | +40.98% | +39.91% | 351B | |
| +1.75% | -0.98% | +26.20% | +39.73% | 290B | |
| +2.13% | -1.53% | +1.85% | +9.40% | 243B | |
| +1.41% | +2.65% | +45.34% | +62.43% | 227B | |
| +1.35% | -3.20% | -9.07% | -53.51% | 200B | |
| +3.25% | +5.65% | +21.57% | +89.04% | 172B | |
| Average | +2.81% | -0.64% | +31.29% | +48.99% | 401.39B | |
| Weighted average by Cap. | +2.79% | -0.18% | +44.17% | +68.06% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.53B 444M 383M 361M 328M 617M 626M 4.23B 1.66B 21.27B 1.67B 1.63B 70.85B | 47.17B 492M 425M 400M 364M 684M 694M 4.69B 1.84B 23.59B 1.85B 1.81B 78.58B |
| Net income | 11.61B 121M 105M 98.48M 89.5M 168M 171M 1.16B 453M 5.81B 455M 445M 19.34B | 13.36B 139M 120M 113M 103M 194M 197M 1.33B 521M 6.68B 524M 512M 22.26B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | ₹2,877.40 | +6.46% | 477,841 |
| 17/08/26 | ₹2,702.90 | +0.52% | 84,337 |
| 14/08/26 | ₹2,688.80 | +0.79% | 94,952 |
| 13/08/26 | ₹2,667.70 | +1.81% | 59,367 |
| 12/08/26 | ₹2,620.20 | +0.70% | 64,718 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 500660 Stock
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
